It has been observed that both AFP and PIVKA-II increased over time in patients that developed HCC, but among HCC-free controls the time-related changes of PIVKA-II were more stable than AFP; a 5% increase of Log10 PIVKA-II serum values resulted significantly for the prediction of HCC development. This evidence concerns the gene AFP and hepatocellular carcinoma.